Volufiline 92% + Pal-Isoleucine 1% Plumping Anhydrous Serum
Ingredient-Nerd Experiment
Verified reviewer
Pros & cons.
- +Delivers Volufiline in the highest practical load on the market
- +Short, fragrance-free, silicone-free ingredient deck with nothing to hide
- +Anhydrous format preserves oxidation-prone actives without preservatives
- +Layers cleanly under sunscreen and makeup when not overapplied
- +Fungal-acne safe and compatible with retinoids and acids
- +Priced aggressively against other Volufiline-based serums
- +Lightweight oil-gel feel unusual for a product this occlusive
- +Doubles as a buffer over irritating actives like retinoids
- −15 mL is small for twice-daily face-and-neck use
- −Plumping effect is subtle and slow — not a filler replacement
- −Most supporting evidence is manufacturer-driven rather than independent
- −Occlusive base can feel heavy on actively oily or breaking-out skin
- −Offers no water-phase hydration on its own
- −Overapplication leaves a slip layer that disrupts makeup
The full review.
Some The Ordinary launches function as public science experiments. This is one. Volufiline has appeared in other brands’ ingredient lists for over a decade—usually at two or three percent, unnamed on the front, and supporting a more marketable hero like a peptide or a retinoid. Deciem strips everything else away to show what a bottle of essentially just Volufiline does to your face over a few months. The 92% on the label is not a standard concentration; it means this formula is Volufiline and a few structural extras.
The liquid is clear, slightly viscous, and scentless. It is an oil—the base is hydrogenated polyisobutene, a highly refined synthetic hydrocarbon that feels between squalane and a light silicone—but it is less heavy than a traditional plant oil. Rhus succedanea wax adds body so it stays on your fingertips, caprylyl glycol and polyglyceryl-3 stearate distribute the Anemarrhena extract through the oil phase, and tocopherol handles oxidation. That is the whole deck. No water, no preservatives, no competing actives.
Minimalism is the point. Volufiline is hard to formulate: it is oil-soluble, its extract can oxidize, and emulsifying it into a cream usually requires cutting the load to a few percent to survive water and surfactants. An anhydrous formula avoids this. The active reaches skin in its original form, at a load the manufacturer’s own research never tested, inside an occlusive vehicle. If you want to know exactly what is working, this approach is honest.
The case for Volufiline is that sarsasapogenin from Anemarrhena root can encourage lipid accumulation in isolated fat cells, which should subtly plump skin where age-related volume loss has thinned soft tissue. The case against it is that most supporting data comes from the ingredient maker, sample sizes are small, and visible effects in those studies are modest—millimeters and percentage changes, not the lift of a procedure. Both are true. View this serum as a long, slow experiment in lipid support; do not treat it as a filler replacement.
It behaves well in daily use. Press three or four drops into cheeks and the upper neck after a hydrating serum; it sinks in within a minute and leaves a satin finish instead of a greasy film. Layering sunscreen or makeup on top works fine unless you overapply, which causes slip. The first week’s improvement comes from occlusion—skin looks smoother and better hydrated because it is, which helps drier complexions. Any genuine plumping from Volufiline shows up later, around the two-to-three-month mark of twice-daily use, and the change is quiet.
Palmitoyl isoleucine at one percent is the other ingredient Deciem wants you to notice. It is a lipoamino acid, not a signal peptide, so it does not behave like a matrixyl or an argireline—it sits in the lipid matrix as a supporting conditioner for the same adipocyte story. It is there partly for mechanism and partly for the label: pairing Volufiline with a named secondary active makes a more compelling product than Volufiline alone, even at a one percent level. It does not hurt the formula and it plausibly helps.
The serum has limits in scope. The 15 mL bottle is small for twice-daily use on the face and neck, and you will likely finish it in six to eight weeks. It is not a moisturizer; skin needing humectant hydration still needs a water-phase product underneath. Because the effect is subtle, use it as an add-on to a routine, not a centerpiece. If your routine already includes sunscreen, retinoids, and barrier support, this layers in as a slow-burn plumping assist. If you lack those fundamentals, spend the twenty-one dollars there first.
At this price, the experiment is easy to justify. Volufiline-forward products elsewhere usually cost more than forty dollars and use much less of the active. If you want to see what Volufiline does to your face without other variables, this is the cheapest and cleanest way to find out—the specific kind of useful The Ordinary does well.
Formula
Formula
Ingredient analysis.
Full INCI list
Hydrogenated Polyisobutene, Caprylyl Glycol, Polyglyceryl-3 Stearate, Palmitoyl Isoleucine, Anemarrhena Asphodeloides Root Extract, Rhus Succedanea Fruit Wax, Tocopherol
Skin match.
The science.
The Science
The Volufiline claim relies on limited research on sarsasapogenin, a steroidal saponin from Anemarrhena asphodeloides. Sederma, the ingredient's maker, ran in vitro studies showing increased lipid accumulation in 3T3-L1 preadipocyte cultures. A 56-day in vivo study showed modest cheek volume gains via silicone replica and 3D imaging. These findings interest cell biologists because saponins act as lipogenic signals, but the data is small-scale, manufacturer-funded, and lacks independent peer-reviewed replication. This anhydrous formula removes confounders: by excluding water, surfactants, and secondary actives, it delivers the Anemarrhena extract in the same lipid carrier used in the original studies, but at a higher load. Whether this increases the effect on human facial skin remains unknown, as the published dose-response plateaus below these levels. Palmitoyl isoleucine is the secondary component: a lipoamino acid that sits in the stratum corneum lipid phase like a conditioner. It aims to support adipocyte biology rather than using the cell-signaling pathways used by peptides like Matrixyl. Evidence for this is sparser and mostly mechanistic. The science suggests these components have plausible mechanisms and early-stage evidence; this formulation is the cleanest way to test them on skin. Users should expect "subtle surface plumping over months" instead of "visible volume restoration."
Dermatologist Perspective
Dermatologists view ingredients like Volufiline as promising-but-unproven adjuncts. They are low-risk additions to a routine, but not strong enough to replace evidence-based aging strategies. The foundation for treating age-related volume loss and skin thinning remains daily broad-spectrum sunscreen, a tolerated retinoid, and barrier-supporting moisturizers; everything else is a secondary layer. This product fits as a secondary layer in a complete routine, especially for patients wanting new actives without extra irritation risk. Board-certified dermatologists note that fragrance-free, short ingredient lists benefit reactive or menopausal skin, which overlaps with the "loss of volume" audience this serum targets. Clinical expectations must stay realistic: any visible plumping will be modest, gradual, and additive to sunscreen and retinoid use, not a substitute for them.
Where it fits in your routine.
After cleansing and applying water-based serums, press three to four drops between your fingertips. Pat the liquid across your cheeks, mid-face, and upper neck to target visible volume loss. The anhydrous base locks in what is beneath it, so layer hydrators first. Use your usual moisturizer morning and night, plus sunscreen in the morning. It works with retinoids; apply the retinoid first, let it absorb, then apply this on top. The occlusive polyisobutene base helps buffer retinoid dryness. Avoid active acne zones during a breakout. Use the product consistently for 8–12 weeks before deciding if the plumping effect is worth continuing.
At $21.40 for 15 mL, this costs about half as much as other Volufiline-forward serums and has a higher active load. This offers good value for those testing this ingredient. The size is the drawback: twice-daily use empties the bottle in under two months, costing roughly a dollar a week for a subtle, slow-acting effect. Compared to a conventional peptide serum at a similar price with twice the volume, the per-day math is worse. View the value as an ingredient experiment rather than a routine staple — the price allows for an honest experiment, but not casual stacking of multiple bottles.
This works for people aged late 30s and up with dry or normal skin. It fits users with complete routines — sunscreen, retinoid, barrier support — seeking a low-risk, ingredient-driven add-on for subtle surface plumping. It is also a sensible pick for ingredient obsessives testing what Volufiline does on their own face.
Skip this if you have oily or acne-prone skin and find occlusive oils heavy, if you lack sunscreen and retinoids and hope this replaces them, or if you expect results like an in-office volumizing procedure. The 15 mL bottle also fails to cover the face, neck, and décolleté at once.
Product details.
Almost none — the hydrogenated polyisobutene base has a faint, neutral lipid note.
15 mL frosted glass dropper bottle with the standard Deciem white-and-grey label.
The first use feels conditioning—like a clean facial oil that sinks in fast. It has no tingle, no scent, and no adjustment period. Most people see a softer surface within a week; visible plumping builds slowly over two-to-three months.
Roughly 6–8 weeks with twice-daily face-only use of 3–4 drops.
12 months
fall winter
The backstory.
Volufiline has been floating around indie and K-beauty formulations since Sederma introduced it over a decade ago, usually as a quiet supporting ingredient. The Ordinary's move here — stripping the formula to almost nothing but Volufiline itself — is classic Deciem: take a trademarked active that has always been hidden, put it on the label at an almost absurd concentration, and let consumers decide.
About The Ordinary
Established Brand (5–20 years)The Ordinary launched in 2016. Deciem created it to provide studied actives at cost-plus pricing. After more than a decade, dermatologists on social media widely recommend its product range. It is a reference point for ingredient-first formulating, even if individual launches vary in their independent clinical backing.
Common myths.
Volufiline grows new fat cells in your face to plump it.
In vitro studies show Volufiline stimulates lipid accumulation in isolated adipocytes. However, the effect on adult human facial fat pads is modest and does not match a volumizing procedure. View any plumping as surface smoothing and lipid replenishment, not true volume restoration.
At 92% Volufiline, it works 20x better than a 5% Volufiline product.
Dose-response for this ingredient plateaus well below 92%, and most published work uses 2–5% levels. The high number is striking on the label but the practical ceiling of the effect is likely similar to well-formulated competitors.
FAQ.
What does Volufiline actually do in this serum?
Volufiline carries Anemarrhena asphodeloides root extract in hydrogenated polyisobutene. In this formula, it forms almost the entire oil phase. This ensures every drop delivers the highest practical active load Deciem can build. Consistent use for 2–3 months claims to improve surface plumpness.
Myth
Will this serum replace filler or a volumizing procedure?
Reality
No. Even optimistic manufacturer data shows Volufiline provides subtle lipid support and surface smoothing, not restoration of deep facial fat pads. If volume loss is serious enough to consider filler, this serum complements rather than substitutes.
How to Use
Can I layer this with retinoids or acids?
Yes. The anhydrous, acid-free formula prevents pH conflict. Apply your retinoid or exfoliant first, let it absorb, then layer this on top. The oil-phase film buffers retinoid dryness — a useful pairing if you have irritation-prone skin.
Best for
Is it safe for acne-prone skin?
The formula is fungal-acne-safe and contains no classically comedogenic ingredients, but the high occlusive polyisobutene load means some people with actively breaking-out oily skin will feel it sits heavy. If you're in an acne flare, stick to drier areas or wait until skin calms.
Packaging
Why is the bottle so small?
The Ordinary uses 15 mL for higher-cost-actives launches to keep the entry price under $25. Use 3–4 drops twice a day on the face only; the supply lasts 6–8 weeks.
Works for
Does it work on the body or neck?
The ingredient deck is safe for the neck and décolleté. However, the 15 mL size makes body use impractical. If you want Volufiline for the neck, this serum works for the face only.
What the community says.
"Lightweight oil feel despite high polyisobutene load"
"Short, fragrance-free ingredient list"
"Fair price point for a Volufiline-forward product"
"Small 15 mL size relative to twice-daily use"
"Plumping effect is subtle at best"
"Feels slippery under makeup if over-applied"
People also looked at.
